Myomo Inc (MYO) Stock Price, Quote & News

Company Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interfac...

Industry: Medical Devices

Sector: Healthcare

Phone: 617 996 9058

Website: myomo.com

Address:

45 Blue Sky Dr., Suite 101, Burlington, United States

Meatloaf44 May. 13 at 6:09 PM

$MYO got a bunch at .78 earnings looked like they showed improvement to me.

0 · Reply

kurtb1969 May. 13 at 3:51 PM

$MYO that's the chart I like, I had 220k shares at $0.67 average cost in January 2023. I sold the last of it December 2024 over $5. I started buying again when it hit $3 and really loaded again under $1. We will hit $7 again no doubt the question is in 6 months or 3 years?

0 · Reply

Meatloaf44 May. 12 at 10:55 PM

$MYO breakout and re test of the 50 day MA. No brainer here if you wanna risk a 5-10% stop. Bought a bunch.

0 · Reply

FERRARISF90 May. 12 at 3:15 PM

$MYO thank you noobs for the upgrade

2 · Reply

kurtb1969 May. 12 at 1:56 PM

$MYO

1 · Reply

FERRARISF90 May. 12 at 1:50 PM

$MYO but, but, but...didn't the board by $8,000 worth of stock?! But, but, but didnt management buy it at $3.50? 🤣

0 · Reply

FERRARISF90 May. 12 at 1:41 PM

$MYO do I have your attn? C'mon bulls. Show me your positions. Who has the balls? Bunch of bag holding

0 · Reply

FERRARISF90 May. 11 at 2:56 PM

$MYO 🤡💩

0 · Reply

FERRARISF90 May. 11 at 2:55 PM

$MYO 😂

0 · Reply

fitchbuck May. 10 at 4:16 PM

$MYO I see on LinkedIn where they're celebrating "candy man" Paul's 15yr company anniversary. They even broke out the Hershey syrup & whip cream... man that must've strained the petty cash drawer savings for 2026!

1 · Reply

Myomo reports Q1 EPS (7c), consensus (12c)

2026-05-07T22:42:58.000Z - 5 days ago

Myomo sees Q2 revenue $10.3M-$10.8M, consensus $10.5M

May 7, 2026, 4:30 PM EDT - 5 days ago

Myomo Earnings Call Transcript: Q1 2026

May 7, 2026, 4:05 PM EDT - 5 days ago

Myomo Reports First Quarter 2026 Financial and Operating Results

2026-05-04T20:12:26.000Z - 8 days ago

Myomo announce availability of MyoPro at Ottobock Care Clinics

May 4, 2026, 4:05 PM EDT - 8 days ago

Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S.

May 1, 2026, 4:05 PM EDT - 11 days ago

Myomo to Report First Quarter 2026 Financial Results on May 7

2026-04-20T20:10:31.000Z - 22 days ago

Myomo launches Myomo Mobile App

Apr 20, 2026, 4:05 PM EDT - 22 days ago

Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement

Apr 16, 2026, 4:05 PM EDT - 26 days ago

Myomo Appoints William J Febbo to its Board of Directors

2026-03-12T11:11:26.000Z - 2 months ago

Myomo price target lowered to $3 from $4 at Alliance Global

Mar 9, 2026, 4:30 PM EDT - 2 months ago

Myomo Earnings Call Transcript: Q4 2025

2026-03-09T20:17:10.000Z - 2 months ago

Myomo sees FY26 revenue $43M-$46M, consensus $46.97M

2026-03-09T20:16:51.000Z - 2 months ago

Myomo sees Q1 revenue $9M-$9.5M, consensus $10.78M

2026-03-09T20:15:14.000Z - 2 months ago

Myomo, Elevance agree to contract for multi-state network participation

ELV

2026-03-09T20:10:28.000Z - 2 months ago

Myomo reports Q4 EPS (9c), consensus (9c)

Mar 9, 2026, 4:06 PM EDT - 2 months ago

Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 9, 2026, 4:05 PM EDT - 2 months ago

Myomo and Elevance Health Agree to Contract for Multi-State Network Participation

Mar 2, 2026, 4:05 PM EST - 2 months ago

Myomo to Report Fourth Quarter 2025 Financial Results on March 9

Nov 10, 2025, 4:30 PM EST - 6 months ago

Myomo Earnings Call Transcript: Q3 2025

2025-11-10T21:16:40.000Z - 6 months ago

Myomo reports Q3 EPS (9c) , consensus (11c)

2025-11-10T21:16:12.000Z - 6 months ago

Myomo backs FY25 revenue view of $40M-$42M, consensus $40.19M

Nov 10, 2025, 4:05 PM EST - 6 months ago

Myomo Reports Third Quarter 2025 Financial and Operating Results

Nov 3, 2025, 4:05 PM EST - 6 months ago

Myomo to Report Third Quarter 2025 Financial Results on November 10

Sep 2, 2025, 4:05 PM EDT - 9 months ago

Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference

2025-08-13T01:02:00.000Z - 9 months ago

MYO Earnings: Guidance Cut Slams Myomo Stock

2025-08-12T10:21:01.000Z - 9 months ago

Myomo price target lowered to $5 from $9.50 at H.C. Wainwright

Aug 11, 2025, 4:30 PM EDT - 9 months ago

Myomo Earnings Call Transcript: Q2 2025

2025-08-11T20:22:04.000Z - 9 months ago

Myomo reports Q2 EPS (11c), consensus (11c)

2025-08-11T20:21:50.000Z - 9 months ago

Myomo cuts FY25 revenue view to $40M-$42M from $50M-$53M

Aug 11, 2025, 4:05 PM EDT - 9 months ago

Myomo Reports Second Quarter 2025 Financial and Operating Results

Aug 4, 2025, 4:05 PM EDT - 10 months ago

Myomo to Report Second Quarter 2025 Financial Results on August 11

2025-06-26T11:05:35.000Z - 11 months ago

Myomo price target lowered to $6.50 from $6.75 at Alliance Global Partners

2025-06-23T17:47:09.000Z - 11 months ago

Myomo price target lowered to $8 from $10 at Craig-Hallum

Jun 18, 2025, 10:00 AM EDT - 11 months ago

Myomo Transcript: Investor Day 2025

Jun 18, 2025, 8:30 AM EDT - 11 months ago

Myomo Provides Highlights of Today's Investor & Analyst Day Event

2025-05-08T13:39:13.000Z - 1 year ago

Myomo price target lowered to $10 from $11 at Craig-Hallum

May 7, 2025, 5:11 PM EDT - 1 year ago

Myomo Reports First Quarter 2025 Financial and Operating Results

May 7, 2025, 4:30 PM EDT - 1 year ago

Myomo Earnings Call Transcript: Q1 2025

May 1, 2025, 8:30 AM EDT - 1 year ago

Myomo to Host Investor & Analyst Day Event on June 18, 2025

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Myomo to Report First Quarter 2025 Financial Results on May 7

Apr 30, 2025, 8:05 AM EDT - 1 year ago

Myomo Launches the MyoPro® 2x

Apr 10, 2025, 3:00 PM EDT - 1 year ago

Myomo Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 10, 2025, 8:30 AM EDT - 1 year ago

Myomo Announces Upcoming Changes to its Board of Directors

Mar 31, 2025, 4:05 PM EDT - 1 year ago

Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Myomo Earnings Call Transcript: Q4 2024

Mar 10, 2025, 4:05 PM EDT - 1 year ago

Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million

Mar 3, 2025, 4:05 PM EST - 1 year ago

Myomo to Report Fourth Quarter 2024 Financial Results on March 10

Dec 5, 2024, 7:30 AM EST - 1 year ago

Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock

Dec 4, 2024, 4:05 PM EST - 1 year ago

Myomo, Inc. Announces Proposed Public Offering of Common Stock

Nov 6, 2024, 4:30 PM EST - 1 year ago

Myomo Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

Myomo Reports Record Third Quarter Financial and Operating Results

Oct 31, 2024, 4:05 PM EDT - 1 year ago

Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage

Oct 30, 2024, 4:05 PM EDT - 1 year ago

Myomo to Report Third Quarter Financial Results on November 6, 2024

Oct 16, 2024, 10:30 AM EDT - 1 year ago

Myomo Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 9, 2024, 4:05 PM EDT - 1 year ago

Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 12, 2024, 8:30 AM EDT - 1 year ago

Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly

Sep 5, 2024, 4:15 PM EDT - 1 year ago

Myomo to Participate in Two Investor Conferences in September

Aug 6, 2024, 4:30 PM EDT - 1 year ago

Myomo Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Myomo Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 4:05 PM EDT - 1 year ago

Myomo to Report Second Quarter Financial Results on August 6, 2024

Jul 8, 2024, 8:30 AM EDT - 2 years ago

Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics

Jun 12, 2024, 10:00 AM EDT - 2 years ago

Myomo Transcript: Small-Cap Growth Virtual Investor Conference

Jun 5, 2024, 5:58 PM EDT - 2 years ago

Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

Myomo Earnings Call Transcript: Q1 2024

May 8, 2024, 4:05 PM EDT - 2 years ago

Myomo Reports First Quarter 2024 Financial Results

May 6, 2024, 8:30 AM EDT - 2 years ago

Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees

May 1, 2024, 5:21 PM EDT - 2 years ago

Myomo to Report First Quarter Financial Results on May 8, 2024

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Myomo Appoints Heather Getz to its Board of Directors

Mar 7, 2024, 4:30 PM EST - 2 years ago

Myomo Earnings Call Transcript: Q4 2023

Mar 7, 2024, 4:05 PM EST - 2 years ago

Myomo Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 1, 2024, 8:00 AM EST - 2 years ago

CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®

Feb 29, 2024, 4:05 PM EST - 2 years ago

Myomo to Report Fourth Quarter Financial Results on March 7, 2024

Jan 19, 2024, 4:05 PM EST - 2 years ago

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Jan 17, 2024, 8:05 AM EST - 2 years ago

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Jan 17, 2024, 8:00 AM EST - 2 years ago

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Nov 7, 2023, 4:30 PM EST - 2 years ago

Myomo Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:05 PM EST - 2 years ago

Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations

Nov 6, 2023, 8:30 AM EST - 2 years ago

CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting

Nov 2, 2023, 10:08 AM EDT - 2 years ago

Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category

Oct 31, 2023, 4:05 PM EDT - 2 years ago

Myomo to Report Third Quarter Financial Results on November 7, 2023

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Myomo Announces Closing of $4.4 Million Public Offering

Aug 25, 2023, 7:00 AM EDT - 2 years ago

Myomo Announces Pricing of $4.4 Million Public Offering

Meatloaf44 May. 13 at 6:09 PM

$MYO got a bunch at .78 earnings looked like they showed improvement to me.

0 · Reply

kurtb1969 May. 13 at 3:51 PM

0 · Reply

Meatloaf44 May. 12 at 10:55 PM

$MYO breakout and re test of the 50 day MA. No brainer here if you wanna risk a 5-10% stop. Bought a bunch.

0 · Reply

FERRARISF90 May. 12 at 3:15 PM

$MYO thank you noobs for the upgrade

2 · Reply

kurtb1969 May. 12 at 1:56 PM

$MYO

1 · Reply

FERRARISF90 May. 12 at 1:50 PM

$MYO but, but, but...didn't the board by $8,000 worth of stock?! But, but, but didnt management buy it at $3.50? 🤣

0 · Reply

FERRARISF90 May. 12 at 1:41 PM

$MYO do I have your attn? C'mon bulls. Show me your positions. Who has the balls? Bunch of bag holding

0 · Reply

FERRARISF90 May. 11 at 2:56 PM

$MYO 🤡💩

0 · Reply

FERRARISF90 May. 11 at 2:55 PM

$MYO 😂

0 · Reply

fitchbuck May. 10 at 4:16 PM

1 · Reply

kurtb1969 May. 9 at 4:02 PM

$MYO so weird astound is worth $10S of millions of dollars and he spend hours each day putting down this nano cap biotechnology company that is genuinely helping people. I'm guessing his boy friend has a myopro arm and ripped his dck off while giving him a hand job. It's the only logical explanation.

2 · Reply

Theflash88 May. 8 at 8:25 PM

$MYO $VKTX Hopefully in 3 months.

0 · Reply

IGot5kOnIt May. 8 at 8:19 PM

$MYO I’ll going to continue to hold this stock. As time goes on the need for companies like this will just continue to increase.

1 · Reply

kurtb1969 May. 8 at 7:50 PM

$MYO this company is instantly profitable to a larger Company as an acquisition target. The overhead of being a public weighs. Salespeople selling only 1 product weighs. They make 68 percent gross profit on product sales. Ottobock I think will eventually acquire myo, it's a perfect fit.

0 · Reply

FERRARISF90 May. 8 at 7:28 PM

$MYO now you understand. Wax on wax off.

0 · Reply

kurtb1969 May. 8 at 7:19 PM

$MYO there is no dilution event happening this quarter or next they have $15 million in cash. When they have done a dilution usually the executives are some of the buyers. Myo has never repriced their executives options. If you are a money losing company the reason you are public is to raise cash at times, it is the price of doing business.

0 · Reply

Bulltrader988 May. 8 at 7:18 PM

$MYO Yesterday 👃👀

0 · Reply

FERRARISF90 May. 8 at 7:17 PM

$MYO oh no what's happening? Oh wait but it reached .93! 🤣😂😅 ya dumb noobs.

0 · Reply

FERRARISF90 May. 8 at 7:09 PM

$MYO who is covering now? 🤣🤣🤣 I warned you $.42!

0 · Reply

FERRARISF90 May. 8 at 7:01 PM

$MYO I warned you!!! You guys are just clueless. Rev-cogs is negative qtr after qtr after qtr. Until sales down qtr after qtr. Expenses are higher than revenue! Pure and simple math.

0 · Reply

kurtb1969 May. 8 at 6:04 PM

$MYO I don't understand the hate and venom for this company on this board. Current management has increased sales at a very fast rate and this product actually improves people's lives.

4 · Reply

FERRARISF90 May. 8 at 4:55 PM

$MYO warned you noobs! Jesus, youre still sticking around the worst small cap performer in the entire small cap universe.

0 · Reply

Market Cap	32.84M
Revenue (ttm)	40.93M
Net Income (ttm)	-15.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-38.04%
Debt to Equity Ratio	1.21

Volume	132,350
Avg Vol	353,462
Day's Range	N/A - N/A
Shares Out	38.64M
Stochastic %K	18%
Beta	1.39
Analysts	Strong Sell
Price Target	$4.32